Minnesota Oncology Hematology, P.A. is a clinical research site located in Maplewood, Minnesota, United States 55109.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Minnesota Oncology Hematology, P.A. has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.
Sponsors: Pfizer, Calithera Biosciences, Inc, Dendreon.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Minnesota Oncology Hematology, P.A. has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Minnesota Oncology Hematology, P.A. has 6 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.
Yes — Minnesota Oncology Hematology, P.A. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.